Duke Human Vaccine Institute - Duke Vaccine and Trials Unit — Durham, North Carolina

Duke Human Vaccine Institute - Duke Vaccine and Trials Unit is a clinical research site located in Durham, North Carolina, United States 27704.

Crixeo Clinical Trials Trust Score: 17/100 (FAILING). This profile has not yet been claimed by the site owner.

Duke Human Vaccine Institute - Duke Vaccine and Trials Unit has participated in 9 clinical trials.

Therapeutic areas: Influenza, COVID-19, Bacterial Infection.

Sponsors: National Institute of Allergy and Infectious Diseases (NIAID).

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Durham

Browse all research sites in North Carolina · View every site in Durham

Sponsor Feasibility Report

Trust Score: 17/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Duke Human Vaccine Institute - Duke Vaccine and Trials Unit?

Duke Human Vaccine Institute - Duke Vaccine and Trials Unit has a Crixeo Trust Score of 17/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Duke Human Vaccine Institute - Duke Vaccine and Trials Unit conducted?

Duke Human Vaccine Institute - Duke Vaccine and Trials Unit has 9 clinical trials on record. Their work covers Influenza, COVID-19, Bacterial Infection.

Is Duke Human Vaccine Institute - Duke Vaccine and Trials Unit accredited by Crixeo Clinical Trials?

Duke Human Vaccine Institute - Duke Vaccine and Trials Unit has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Duke Human Vaccine Institute - Duke Vaccine and Trials Unit?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.